Cubist Systematic Strategies’s Recursion Pharmaceuticals RXRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-30,920
| Closed | -$308K | – | 2431 |
|
|
2024
Q1 | $308K | Buy |
30,920
+17,816
| +136% | +$178K | ﹤0.01% | 1523 |
|
|
2023
Q4 | $129K | Buy |
+13,104
| New | +$129K | ﹤0.01% | 1739 |
|
|
2023
Q2 | – | Sell |
-406,662
| Closed | -$2.71M | – | 2907 |
|
|
2023
Q1 | $2.71M | Buy |
406,662
+246,829
| +154% | +$1.65M | 0.02% | 944 |
|
|
2022
Q4 | $1.23M | Buy |
159,833
+48,258
| +43% | +$372K | 0.01% | 1613 |
|
|
2022
Q3 | $1.19M | Buy |
111,575
+88,167
| +377% | +$938K | 0.01% | 1945 |
|
|
2022
Q2 | $191K | Sell |
23,408
-65,340
| -74% | -$533K | ﹤0.01% | 3196 |
|
|
2022
Q1 | $635K | Buy |
88,748
+54,971
| +163% | +$393K | 0.01% | 2366 |
|
|
2021
Q4 | $579K | Buy |
33,777
+6,091
| +22% | +$104K | 0.01% | 2338 |
|
|
2021
Q3 | $637K | Buy |
27,686
+14,086
| +104% | +$324K | 0.01% | 1858 |
|
|
2021
Q2 | $496K | Buy |
+13,600
| New | +$496K | 0.01% | 2016 |
|